中興(00763.HK)斥26.1億人幣增持中興微電子 建議配發A股
中興(00763.HK)(000063.SZ)公布,就有關向恆健欣芯和匯通融信,收購中興微電子18.8219%股權一事,目前對價詳情及擬發行的對價股份數量已釐定及確定。
公司指,現時收購事項總值為26.11億元人民幣,各方同意公司以配發與發行對價股份方式支付對價,即向恆健欣芯和匯通融信分別發行4,564.38萬股及3,912.33萬股。
對價股份為每股30.8元人民幣,較公司H股10月28日收市價溢價86.18%,並發行8,476.71萬股,佔A股股份總數2.2%,或已發行股份總數1.84%。
另外,公司建議非公開發行A股募集配套資金,金額不多於是次收購對價,即26.1億元人民幣,將用於5G關鍵芯片研發項目和補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.